Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.345 USD | +3.16% | -11.04% | +61.10% |
05-09 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.10% | 454M | |
+5.06% | 109B | |
+11.15% | 105B | |
-0.38% | 22.25B | |
-12.12% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.03% | 16.85B | |
+3.32% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Transcript : Larimar Therapeutics, Inc. - Special Call